Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 11.
doi: 10.1038/s41587-024-02504-9. Online ahead of print.

Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration

Affiliations

Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration

Keqiang Xie et al. Nat Biotechnol. .

Abstract

The use of adeno-associated viruses (AAVs) as donors for homology-directed repair (HDR)-mediated genome engineering is limited by safety issues, manufacturing constraints and restricted packaging limits. Non-viral targeted genetic knock-ins rely primarily on double-stranded DNA (dsDNA) and linear single-stranded DNA (lssDNA) donors. dsDNA is known to have low efficiency and high cytotoxicity, while lssDNA is challenging for scaled manufacture. In this study, we developed a non-viral genome writing catalyst (GATALYST) system that allows production of circular single-stranded DNAs (cssDNAs) up to approximately 20 kilobases as donor templates for highly efficient precision transgene integration. cssDNA donors enable knock-in efficiency of up to 70% in induced pluripotent stem cells (iPSCs) and improved efficiency in multiple clinically relevant primary immune cell types and at multiple genomic loci implicated for clinical applications with various nuclease editor systems. The high precision and efficiency in chimeric antigen receptor (CAR)-T and natural killer (NK) cells, improved safety, payload flexibility and scalable manufacturability of cssDNA shows potential for future applications of genome engineering.

PubMed Disclaimer

Conflict of interest statement

Competing interests: K.X., J.S., I.M., J.W., K.R., T.T., D.L., S.N., J.F., R.S. and H.W. are either current or former employees of Full Circles Therapeutics. Patents related to this study have been filed. The other authors declare no competing interests.

References

    1. Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature 543, 113–117 (2017). - PubMed - PMC - DOI
    1. Salsman, J. & Dellaire, G. Precision genome editing in the CRISPR era. Biochem. Cell Biol. 95, 187–201 (2017). - PubMed - DOI
    1. Quadros, R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol. 18, 92 (2017). - PubMed - PMC - DOI
    1. Li, H. B. et al. Design and specificity of long ssDNA donors for CRISPR-based knock-in. Preprint at bioRxiv https://doi.org/10.1101/178905 (2019).
    1. Bai, H. et al. CRISPR/Cas9-mediated precise genome modification by a long ssDNA template in zebrafish. BMC Genomics 21, 67 (2020). - PubMed - PMC - DOI

LinkOut - more resources